Novo & Hims Partner on Ozempic & Wegovy – Lawsuit Dropped

Novo Nordisk and Hims & Hers end their legal battle and team up to offer FDA-approved Ozempic and Wegovy (injections and pills) on the Hims platform. Hims shifts its focus to branded GLP-1s with limited compounded options. Shares surge.

Novo & Hims Partner on Ozempic & Wegovy – Lawsuit Dropped
Credit: Hims & Hers Health
Already have an account? Sign in.